Company Filing History:
Years Active: 2010-2012
Title: The Innovative Contributions of Jeffrey Chisholm in Patent Development
Introduction
Jeffrey Chisholm is a notable inventor based in Mountain View, CA. With a commendable portfolio consisting of three patents, Chisholm has made significant strides in the field of pharmaceutical innovation, particularly focusing on compounds that serve as inhibitors for specific enzymes linked to various human diseases.
Latest Patents
Chisholm's most recent patents showcase his dedication to addressing health-related challenges. The first patent introduces 3,4-dihydroquinoxalin-2(1H)-ones for use as stearoyl-CoA desaturase inhibitors. This invention proposes the compounds as beneficial in treating and preventing diseases associated with stearoyl-CoA desaturase (SCD) enzymes, particularly those related to abnormal lipid levels, cardiovascular disease, diabetes, obesity, oily skin conditions, and metabolic syndrome. His second patent focuses on pyrido[2,3-B]pyrazinones, which share a similar purpose as inhibitors of stearoyl-CoA desaturase and similarly target various health concerns linked to SCD enzymes.
Career Highlights
Throughout his career, Jeffrey Chisholm has contributed significantly to the biotechnology and pharmaceutical sectors, having worked with esteemed companies including Gilead Palo Alto, Inc. and Gilead Sciences, Inc. His work has been pivotal in advancing therapeutic options that address critical health issues affecting populations globally.
Collaborations
Collaboration has played an integral role in Chisholm's accomplishments. Notably, he has worked alongside talented professionals such as Dmitry Koltun and Jeff A. Zablocki, contributing to the overlapping fields of patent development and pharmaceutical research. These cooperative efforts have bolstered innovation and allowed for interdisciplinary approaches to complex health challenges.
Conclusion
In summary, Jeffrey Chisholm's inventive spirit and practical applications of his research are evident through his active patents and collaborations. His work as an inventor not only contributes to the scientific community but also aims to provide solutions to critical health issues, showcasing the importance of innovation in the pharmaceutical landscape.